A young man with a long history of abnormal bleeding was seen in January 1985. Coagulation tests showed dysfibrinogenemia and an antifibrinogen autoantibody was demonstrable in his serum. This antibody, when purified, was capable of inhibiting the polymerization of normal fibrin monomers, apparently through binding to the a fibrinogen chain. 6 mo later the patient was asymptomatic, coagulation tests were normal, and the antifibrinogen autoantibody was barely detectable. At this time, affinity-purified autologous and rabbit antifibrinogen antibodies were capable of absorbing an IgG kappa antibody from the patient's serum, which reacted indistinctly with both autologous and xenogeneic antifibrinogen antibodies in enzyme immunoassays. It has been concluded that the patient's dysfibrinogenemia was the result of an antifibrinogen autoantibody, and that later on an antiidiotype antibody, which binds an interspecies cross-reactive idiotype expressed on anti-human fibrinogen antibodies, inhibited the production of the antifibrinogen autoantibody which led to the remission of the disorder.
Introduction
The presence of auto anti-Id antibodies, directed towards Ids expressed on antibodies against exogenous (1) (2) (3) as well as endogenous (4) (5) (6) (7) (8) antigens, has been widely documented in humans. In fact, it is presumable that the expression of autoimmune humoral immune responses might be modulated, ita, est, augmented, or depressed, by anti-Id antibodies (6, 9-1 1) . The production of autoantibodies directed to fibrinogen as a cause of dysfibrinogenemia has been observed in the past (12) (13) (14) (15) . In some instances, these antibodies interfere with fibrinogen clotting by inhibiting the cleavage of fibrinopeptides A and B by thrombin, while in other instances they block the polymerization of fibrin monomers after thrombin cleavage.
This report refers to a case of autoimmune dysfibrinogenemia that was due to an antibody that inhibited fibrin polymerization, in which a spontaneously produced anti-Id autoantibody caused the inhibition of the antifibrinogen autoantibody and led to the clinical remission of the hemorrhagic disorder. This anti-Id antibody was shown to react with xenogeneic antifibrinogen antibodies, hence, its specificity is an interspecies cross-reactive Id (IdX)' most likely encoded by germline V-region genes.
Methods
Case report. A 22-yr-old male patient with a long history of abnormal bleeding was referred to Laboratorios Clinicos de Puebla in January 1985. For 10 yr he had presented a moderate to severe bleeding tendency characterized by recurrent bleeding for several days from lacerations or dental procedures, soft tissue hematoma formation after mild trauma, and one episode of intraarticular bleeding. He had no family history ofbleeding disorders or autoimmune diseases. Although he was seen by several physicians, a definite diagnosis ofhis hemostatic abnormality was never established. When first studied in our clinic he had abnormally prolonged thrombin and reptilase times (16, 17) , while the clottable fibrinogen was < 10% ofthe total fibrinogen mass as detected by immunological and thermoprecipitation methods (18) . Reptilaseinduced fibrin polymerization (17) (20) . The chain specificity of the antifibrinogen antibody was analyzed by immunoblotting (21) ; native purified fibrinogen, as well as samples that were either reduced by 2-mercaptoethanol (2ME) (22) (24, 25) . Briefly, electrophoresis was performed in 0.9% agarose gels (lot IO1F-0183; Sigma) in barbital buffer pH 8.6, ionic strength 0.05. Gels were placed in a precooled flat-bed electrophoresis chamber (Multiphor; LKB Instruments, Inc., Gaithersburg, MD) and after sample application, a constant voltage of 20 V cm-' was applied for 15 min. Gels were placed in a humid chamber and each lane was covered with acetate cellulose strips that had been previously soaked in the different antisera. After a 1-h incubation, the strips were removed and the gels were washed in 0.15 M NaCl for 48 h before drying them and staining the precipitated proteins with Coomassie Brilliant Blue dye (lot 11128; LKB Instruments).
Determination of the functional effects of the autoantifibrinogen antibody. This was achieved by preincubating purified normal human fibrinogen (0.6 g/liter in 0.15 M NaCl) with either 5% (vol/vol) normal serum, 5% (vol/vol) patient's serum, normal human IgG at a final concentration of 110 gg/ml, or the affinity-purified antifibrinogen autoantibody at the same final concentration. Since preliminary experiments showed that the effect of the affinity-purified antibody upon polymerization was not different from that caused by whole serum, the vast majority of these experiments were performed using serum samples. After 30-min incubations of the aforementioned mixtures, fibrin-monomer aggregation was induced either with reptilase (17) , thrombin (26) , or sequential reptilase-thrombin as described by Hensechen et al. (18) . Detection ofpolymerization was done by laser nephelometry as previously reported (17) . To assess the effect of the antifibrinogen antibody on the association of fibrin monomers after the fibrinopeptide cleavage step, monomers were prepared from purified fibrinogen in acetic acid and their aggregation was induced by neutralizing the medium (26) after the addition of serum samples or Igs as described above. To further confirm preliminary results, normal fibrinogen was treated with thrombin in the presence of either patient's or control serum samples according to Kehl et al. (27) . After heat precipitation of fibrin (ogen), the supernatant was analyzed by hydrophobic interaction HPLC using a TSK phenyl 5 PW column (2133-510; LKB, Bromma Sweden) along with a sodium sulfate gradient as descibed by Regnier and Fausnaugh (28) . Additionally, total fibrinopeptide release was measured through quantitating the guanidino group of arginine according to Crum et al. (29) .
Demonstration and isolation ofanti-Id antibodies. The affinity-purified anti-human fibrinogen antibody isolated from the patient's serum was coupled to CnBr-activated Sepharose and packed into columns. Domestically raised rabbit anti-human fibrinogen antibodies were also affinity-purified and coupled to Sepharose beads for chromatography. Serum samples from the patient when in clinical remission and from healthy controls were loaded into the aforementioned columns and allowed to react for 1 h at neutral pH. After complete elution of the unbound material, the pH of the eluent was gradually lowered until all bound antibodies were obtained (20) . The Ig heavy and light chain classes present in this material were analyzed by immunofixation as previously described, and their antibody specificity was assessed by enzyme immunoassay (EIA) in microtiter dishes coated with either autologous or xenogeneic affinity-purified anti-human fibrinogen antibodies. Control plates were coated with 10 gg/ml purified human IgG from different sources. These included five healthy young individuals, three patients with systemic lupus erythematosus, two patients with mixed connective tissue disease, and two patients with IgG Kappa multiple myeloma.
The anti-Id antibody molecules, bound from the patient's serum by the autologous antifibrinogen antibody column, were added in various concentrations to the purified autologous antifibrinogen antibody before testing the effect of the latter on the reptilase-induced aggregation of normal fibrin monomers as described above.
Results
Characteristics of the antifibrinogen autoantibody. As shown in Fig. 1, several When samples containing antifibrinogen antibodies were passed through the insoluble fibrinogen columns, a single peak was eluted at pH 4.0. This peak consisted of gamma and lambda chains only and is seen as a very narrow band in the immunofixation experiments (Fig. 2) , which suggests a monoclonal origin.
When the affinity-purified antifibrinogen antibody was assayed by immunoblotting, it was found to bind to a 350-kD functional fibrinogen assays. The results indicate that the inhibition of fibrn polymerization was not due to interference with fibrinopeptide cleavage by thrombin and/or reptilase, because when this stage was bypassed by thrombin cleavage before the addition of the antibody, the degree of inhibition of polymerization was not different. Moreover, when purified fibrinogen was cleaved by thrombin, the chromatographic pattern ofthe material released in the presence ofthe patient's and the normal subjects' serum samples was identical (Fig. 5) , and the amount of total arginine released in both circumstances was similar, (9.4±0.8 and 9.7±0.9 nmol/mg fibrinogen, respectively), which confirms that the antifibrinogen autoantibody did not interfere with fibrinopeptide cleavage. Characteristics of the anti-Id antibody. Both autologous antifibrinogen antibody as well as rabbit anti-human fibrinogen antibody columns were capable of absorbing significant amounts of Ig from serum samples taken from the patient when he was in clinical remission but not from normal serum. Immunofixation experiments showed that the material eluted from both columns was formed exclusively of gamma and kappa chains. As shown in Fig. 2 , the precipitate consisted ofa narrow band, again suggesting the monoclonal nature of these antibodies. EIAs revealed that the antibody eluted from the autologous antifibrinogen antibody column reacted to a very similar degree with both autologous and xenogeneic antifibrinogen antibodies. On the other hand, antibody absorbed by xenogeneic antifibrinogen antibodies also reacted with the two kinds of antibodies (autologous and xenogeneic). Purified IgG from serum samples taken from five healthy young subjects bound neither to the human nor to the rabbit antifibrinogen antibody-coated dishes (Fig. 6) . The anti-Id antibodies eluted from both columns did not bind to any of the Igs used to coat the control dishes. To rule out the possibility that the binding of the anti-Id antibody to the antifibrinogen antibody-coated EIA plates was due to interaction through its Fc portion, BLAhL a~~~~~- F(ab')2 fragments of the anti-Id antibody were prepared as described (31) and tested in the EIA system against both autologous and rabbit antifibrinogen antibodies. The binding of F(ab')2 fragments was not different from that of the whole antibody molecule. Taken altogether, these results suggest that the antibodies eluted from both columns are in fact a single, perhaps monoclonal, antibody directed to a IdX expressed on anti-human fibrinogen antibodies.
As shown in Fig. 7 , the inhibitory effect ofthe affinity-purified autologous antifibrinogen antibody on the aggregation of fibrin monomers after its induction with reptilase, was reverted by the anti-Id antibody, which was eluted from the autologous antifibrinogen column, in a dose-dependent fashion.
This anti-Id antibody has been present in the patient's serum throughout the duration of the clinical remission.
Discussion
The studies performed on this patient showed that an impairment of fibrinogen polymerization was responsible for his bleeding disorder. The demonstration of the existence of an autoantibody directed against fibrinogen, which was capable of inhibiting fibrin aggregation during the active phase of the hemorrhagic disease but not while the patient was in clinical remission, strongly suggests that the antifibrinogen autoantibody was the cause of the fibrinogen dysfunction. Other cases of autoimmune dysfibrinogenemia have been reported in the past (12) (13) (14) (15) . In some cases the antibody inhibited polymerization of fibrinogen through blocking the cleavage sites for thrombin, while in others the antibody inhibited the aggregation of fibrin monomers after thrombin cleavage. In the case reported herein, the antifibrinogen autoantibody neither interfered with the cleavage of fibrinopeptide A by reptilase, nor with that of fibrinopeptides A and B by thrombin, but it blocked the aggregation process itself. Since the antigenic determinant for this possibly monoclonal antibody seems to be located in the Hi2-DSK fragment of the a fibrinogen chain, it is presumable that the binding of the autoantibody in this highly hydrophilic region interfered with the polymerization process.
The presence of an anti-Id antibody that reacted with, and reverted the effect of, the antifibrinogen autoantibody during the clinical remission, is highly suggestive of an inhibitory role upon the production of the autoantibody. not suppressing the synthesis of the autoantibody, but merely blocking its effect upon fibrinogen, it seems unlikely since, during the clinical remission, no evidence ofimmune complex disease has been found in the patient and because the antifibrinogen antibody has not been detected. The reason why this patient expressed an autoantibody towards fibrinogen, for apparently 10 yr, and spontaneously developed an anti-Id antibody which probably has suppressed the synthesis of the former, remains unexplained.
The fact that the anti-Id antibody reacted also with rabbit anti-human fibrinogen antibodies, indicates that the specificity of this anti-Id antibody is an interspecies IdX. Examples of interspecies IdX, such as the cGATIdX in rodents, and the presence ofthe T15IdX in phosphocholine-binding antibodies raised in both mice and hamsters (32) , have been previously reported. Moreover, it has been observed that goat and sheep antibodies against human sickle cell hemoglobin also share a common Id called ValIdX (32) . Therefore, the presence ofIdX in nonhuman antibodies directed to human proteins has also been documented in the past.
The existence of interspecies IdX is thought to reveal the high degree of conservation of germline V-region genes through the evolution of mammalian species. These genes, as are other highly conserved genes, are believed to confer selective advantages for the species. In this context, and considering the presumable inhibitory role ofthe anti-IdX antibody on the expression ofthe autoantifibrinogen antibody in the case studied herein, one may speculate that antifibrinogen antibodies are normally present at the precursor cell level, but that their expression is down-regulated by the idiotypic network. The search for this antifibrinogen antibody IdX (FibIdX) in precursor cells, and that ofantifibrinogen antibody IdX molecules in healthy mammals, might be useful in proving that the antifibrinogen antibody IdX in fact belongs in the silent repertoire. The finding that IdX on human autoantibodies are largely shared, e.g., the Wa and Po IdX on rheumatoid factors (33) , supports the contention that at least some autoantibodies are encoded by germline genes and might well be silent in the healthy individual. However, the selective advantage of the conservation of these autoantibodies remains to be determined.
